Medical Technology

Michael Giaquinto is a Senior Managing Director in Investment Banking at Leerink Partners covering the Medical Technology sector.

Michael has nearly three decades of healthcare investment banking experience, including 20 years of transactions focused on Medical Technology. Prior to joining the firm in 2018, he served as the Head of Medical Devices & Diagnostics at Greenhill where he spent 10 years dedicated exclusively to providing mergers & acquisitions advisory services to his clients. Prior to Greenhill, Michael spent more than a decade at Citigroup where he served as Co-Head of its U.S. Healthcare Group. Michael also worked in the health care groups of UBS and Kidder, Peabody. He has worked on more than 150 financings and M&A transactions valued at over $100 billion during his career.

He earned his M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University and a B.S. in Accounting from Boston College.

Barry Blake is the Global Co-Head of Investment Banking, and Global Co-Head of Healthcare Investment Banking at Leerink Partners. In this role, he co-leads the firm’s healthcare investment banking strategy and initiatives, with a focus on Healthcare Services & Technology. With 25 years of experience, he has built extensive relationships and has proven expertise in healthcare services, medical devices and tools/diagnostics, leveraged finance, and with financial sponsors. Leading the Healthcare Services team at Leerink Partners, he has advised on numerous transactions, including the sale of LHC Group to Optum Health, a UnitedHealth Group Company, for $6B.

Barry joined the firm in 2021 from Guggenheim Securities where he was a Senior Managing Director focused on advising healthcare services companies. While at Guggenheim he advised on many transactions including, but not limited to, the $10B sale of Envision to KKR; the $4B sale of Kindred Healthcare to a consortium comprised of TPG, Welsh Carson and Humana; the $2.4B sale of American Medical Response to KKR and the $1B sale of Almost Family to LHC Group. Prior to this, he was the Head of Global Healthcare Mergers and Acquisitions for Citigroup. While at Citigroup he worked on many transactions including, but not limited to, the $34B acquisition of Medco by Express Scripts. He also worked in the M&A and Healthcare groups at Morgan Stanley, JP Morgan and Lehman Brothers. While at JP Morgan he advised on many transactions including, but not limited to, the $4.8B acquisition of NextRx from Wellpoint by Express Scripts.

Barry earned his Bachelor of Arts in Economics from Hendrix College, and his Masters of Business Administration with high distinction from the Amos Tuck School at Dartmouth College.

He has served as a member of the Board of Trustees for each of The Hopkins School in New Haven, CT and Hendrix College in Conway, AR.

Christian Clark is a Director and Business Manager of Investment Banking at Leerink Partners. Mr. Clark is responsible for managing the group’s overall operations including strategic planning, financial and business reporting and analytics, people management and recruiting. He supports Healthcare Services & Technology and MD&D investment banking teams.

Mr. Clark joined the firm in 2018 as the Business Manager for Equity Research. He was responsible for managing the Equity Research side of client strategy and for leading many key strategic initiatives in product, process and business development. He was promoted to Associate Director of Equity Research during his time in Equity Research.

Prior to Leerink Partners, Mr. Clark worked at Credit Suisse and held a variety of business and strategy positions within the Equities division. Prior to this role, he was a Fixed Income client consultant at Bloomberg LP.

Mr. Clark earned his B.S. in Finance (Summa Cum Laude) from Pennsylvania State University.